Recent research shows that traditional Chinese medicine Lianhua Qingwen can significantly inhibit replication of the novel coronavirus in cells, which effectively contains COVID-19 infection, Beijing News reported.
The results showed that it could significantly inhibit the replication of SARS-CoV-2 in Vero E6 cells and induce inflammatory factors such as TNF-α, IL-6, CCL2/MCP-1 and CXCL-10/IP-10.
In general, it could significantly inhibit replication of the novel coronavirus and resist inflammation.
The results of the paper, whose authors include the prominent Chinese epidemiologist Zhong Nanshan, and researcher Yang Zifeng of the State Key Laboratory of Respiratory Diseases at Guangzhou Medical University, were released on Pharmacological Research.
The medicine has been widely used in medical institutions including Huoshenshan, Leishenshan and some makeshift hospitals in Wuhan, Hubei Province to fight the epidemic.
Lianhua Qingwen is a very common TCM used for the treatment of colds and flu. Composed of 13 herbal components, it has a curative effect in patients with mild symptoms and helps to relieve fever, coughs and fatigue.
It has been incorporated into the 6th and 7th versions of the diagnosis and treatment plan issued by the state.
Lianhua Qingwen is the first new drug variety approved by China's National Drug Administration's rapid drug approval channel during SARS. It is also the first traditional Chinese medicine for China to enter FDA clinical research in the United States to treat influenza.
China has provided 100,000 boxes of Lianhua Qingwen to hard-hit Italy.
- Wheels on China’s Zhurong rover keep stable with novel material
- Wider vaccination helps China build immune barrier against coronavirus
- Novel carpentry draws millions of online fans
- U.S. targeting China on coronavirus tracing ‘a global open secret’
- Coronavirus more likely to be product of nature than of lab
- Homegrown vaccines withstand coronavirus variants
Popular Videos
Hot comments
- First apes at U.S. zoo receive COVID-19 vaccine made for animals, zoo official says
- China Life: Chinese women shine with She Power
- Foreign firms approved to offer VPN services in capital
- Homemade curling videos trending in China
- 86-year-old grandma in Hebei spends most her life on traditional cheongsam
- Winners of 2022 Inaugural WLA Prize announced
- Lantern Festival: A romantic celebration in China
- Two Chinese COVID-19 vaccine firms to supply vaccines to COVAX
- Media center for 20th CPC national congress to open on Oct. 12
- Six suspects arrested in HK for role in SE Asia job scam
Top Reviews
- Young artists recreate beauty of traditional Hanfu costume
- China releases photos of tallest tree
- English version of ‘Understanding Xi Jinping’s Educational Philosophy’ published
- China crowned in men’s team for 10th straight time at table tennis worlds
- China publishes Atlas of Wildlife in SW China
- Guangxi’s 10 Years: A Visit to China’s Qinzhou Port
- Congress delegate helped lift village out of poverty
- Expo highlights joint efforts in NEV development
- Racism stain of shame on ‘world democratic paradise’
- U.S. may face new COVID wave this upcoming winter: report